Pamidronic Acid

CHEMBL834 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

235.1 g/mol

LogP

-6.9

Phase

4

The free acid form of pamidronate, sharing the same therapeutic uses.

Moleküler Ağırlık

235,0700 g/mol

LogP

-6,90

TPSA

161,00 Å²

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

NCCC(O)(P(=O)(O)O)P(=O)(O)O

InChI

InChI=1S/C3H11NO7P2/c4-2-1-3(5,12(6,7)8)13(9,10)11/h5H,1-2,4H2,(H2,6,7,8)(H2,9,10,11)

Molecular Formula

C3H11NO7P2

HBD / HBA

6 / 8

Döndürülebilir Bağlar

4

Ağır Atomlar

13

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

The free acid form of pamidronate, sharing the same therapeutic uses.

Yes, Pamidronic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL834. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4674. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Pamidronic Acid PillFYI'da

Yapı

Hızlı Veriler

Formül: C3H11NO7P2

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.